What do analysts expect the price target to be for SHARECARE INC (SHCR)?
9 analysts have analysed SHCR and the average price target is 1.46 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.43.
SHARECARE INC (SHCR) Forecast, Price Target & Analyst Ratings
NASDAQ:SHCR • US81948W1045
Current stock price
1.43 USD
-0.01 (-0.35%)
At close:
1.43 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SHARECARE INC (SHCR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Nov 7, 2024
- Period
- Q3 / 2024
- EPS Estimate
- -$0.09
- Revenue Estimate
- 109.04M
Price Target Details & History
Consensus Price Target and Range
Mean target
$1.46
Upside
+ 2.00%
From current price of $1.43 to mean target of $1.46, Based on 9 analyst forecasts
Low
$1.44
Median
$1.46
High
$1.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for SHCR. The average price target is 1.46 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.43.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
48.89%
SHCR was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about SHCR.
In the previous month the buy percentage consensus was at a similar level.
SHCR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-06-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-21 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2024-05-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-04-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-01 | BTIG | Downgrade | Buy -> Neutral |
| 2023-06-02 | BTIG | Reiterate | Buy |
| 2023-03-30 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-11 | Canaccord Genuity | Maintains | Buy |
| 2022-10-05 | BTIG | Maintains | Buy |
| 2022-09-21 | Goldman Sachs | Maintains | Neutral |
| 2022-07-20 | Morgan Stanley | Initiate | Equal-Weight |
| 2022-02-11 | Goldman Sachs | Initiate | Neutral |
| 2021-08-04 | Canaccord Genuity | Initiate | Buy |
| 2021-07-28 | BTIG | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 7, 2024
- Period
- Q3 / 2024
- EPS Estimate
- -$0.09
- Revenue Estimate
- 109.04M
- Revenue Q2Q
- -3.78%
- EPS Q2Q
- -23.86%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
2.54%
EPS (1 Month)
0.00%
EPS (3 Months)
-41.67%
Next Earnings Summary
SHCR is expected to report earnings on 11/7/2024. The consensus EPS estimate for the next earnings is -0.09 USD and the consensus revenue estimate is 109.04M USD.
The next earnings revenue estimate has been revised upward by 2.54% in the past 3 months.
Full Analyst Estimates 2024 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 412.8M 25.55% | 442.4M 7.17% | 445.251M 0.64% | 402.95M -9.50% | 437.42M 8.55% | 477.03M 9.06% | |
| EBITDA YoY % growth | -52.9M -826.65% | -94.04M -77.77% | -74.768M 20.49% | 3.447M 104.61% | 25.376M 636.18% | 25.572M 0.77% | |
| EBIT YoY % growth | -85.5M -391.38% | -139.3M -62.92% | -135.975M 2.39% | -133.039M 2.16% | -92.937M 30.14% | -84.998M 8.54% | |
| Operating Margin | -20.71% | -31.49% | -30.54% | -33.02% | -21.25% | -17.82% | |
| EPS YoY % growth | N/A | -0.34 37.89% | -0.37 -8.82% | -0.35 4.89% | -0.26 27.54% | -0.23 10.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 -23.86% | -0.06 43.90% | -0.04 59.20% | -0.04 66.00% | -0.04 52.94% | -0.02 63.64% |
| Revenue Q2Q % growth | 109.04M -3.78% | 110.62M 5.08% | 102M 12.26% | 106.9M 13.40% | 114.95M 5.42% | 117.3M 6.04% |
| EBITDA Q2Q % growth | -102K -100.73% | 2.849M -88.94% | 204K 100.88% | 714K 106.19% | 918K 1,000.00% | 1.02M -64.20% |
| EBIT Q2Q % growth | -39.78M -33.94% | -31.754M 10.44% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
11.33%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
0.95%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
30.06%
EBIT Next 5 Year
N/A
SHARECARE INC / SHCR Forecast FAQ
What is the next earnings date for SHCR stock?
SHARECARE INC (SHCR) will report earnings on 2024-11-07, before the market open.
What are the consensus estimates for SHARECARE INC (SHCR) next earnings?
The consensus EPS estimate for the next earnings of SHARECARE INC (SHCR) is -0.09 USD and the consensus revenue estimate is 109.04M USD.
What is the consensus rating for SHCR stock?
The consensus rating for SHARECARE INC (SHCR) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.